Search Within

Yu Chen

  1. "2024"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (1)
  3. Review (1)
Groups
  1. Department of Medicine (7)
  2. GSK Faculty (7)
  3. Genitourinary Oncology Service (7)
  4. Human Oncology and Pathogenesis Program (7)
  5. Solid Tumor Oncology Division (7)
  6. Sloan Kettering Institute Postdocs (4)

More Groups

People
  1. Cindy Lee (2)
  2. Dan Li (2)
  3. Ping Chi (2)
  4. Subhiksha Nandakumar (2)
  5. Amish Patel (1)
  6. Fanny Tomas (1)

More People

Years
  1. 2024 (7)
Publications
  1. Clinical Cancer Research (2)
  2. Cancer Discovery (1)
  3. European Journal of Cancer (1)
  4. Nature (1)
  5. PLoS ONE (1)
  6. Science Signaling (1)
Publishers
  1. American Association for Cancer Research (3)
  2. American Association for the Advancement of Science (1)
  3. Elsevier Inc. (1)
  4. Nature Publishing Group (1)
  5. Public Library of Science (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeted CRISPR-Knockout (KO) screening to identify FOXF1 regulators and therapeutic strategies in gastrointestinal stromal tumor (GIST)
    Meeting Abstract

    Tomas, F.; Cho, W. H.; Li, D.; Callychurn, V. R.; Wang, N.; Yu, C.; Chi, P.
    European Journal of Cancer (2024)

    Fulltext@MSK | Save
  • MEK inhibitors lead to PDGFR pathway upregulation and sensitize tumors to RAF dimer inhibitors in NF1-deficient malignant peripheral nerve sheath tumor
    Journal Article

    Miranda-Román, M. A.; Lee, C. J.; Fishinevich, E.; Ran, L.; Patel, A. J.; Yan, J.; Khudoynazarova, M. N.; Warda, S.; Pachai, M. R.; Chen, Y.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • The role of signaling pathways mediated by the GPCRs CysLTR1/2 in melanocyte proliferation and senescence
    Review

    Huber, T.; Horioka-Duplix, M.; Chen, Y.; Saca, V. R.; Ceraudo, E.; Chen, Y.; Sakmar, T. P.
    Science Signaling (2024)

    Fulltext@MSK | Save
  • ZNF397 deficiency triggers TET2-driven lineage plasticity and AR-targeted therapy resistance in prostate cancer
    Journal Article

    Xu, Y.; Yang, Y.; Wang, Z.; Sjöström, M.; Jiang, Y.; Tang, Y.; Cheng, S.; Deng, S.; Wang, C.; Gonzalez, J.; more...
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • Sex differences orchestrated by androgens at single-cell resolution
    Journal Article

    Li, F.; Xing, X.; Jin, Q.; Wang, X. M.; Dai, P.; Han, M.; Shi, H.; Zhang, Z.; Shao, X.; Peng, Y.; more...
    Nature (2024)

    Fulltext@MSK | Save
  • Quantifying Y chromosome loss in primary and metastatic prostate cancer by chromosome painting
    Journal Article

    Rajanala, S. H.; Ghale, R.; Nandakumar, S.; Chadalavada, K.; Lee, G. S. M.; Stopsack, K. H.; Chen, Y.; Nanjangud, G. J.; Chakraborty, G.; Kantoff, P. W.
    PLoS ONE (2024)

    Fulltext@MSK | Save
  • Integrative molecular analyses of the MD Anderson prostate cancer patient-derived xenograft (MDA PCa PDX) series
    Journal Article

    Anselmino, N.; Labanca, E.; Shepherd, P. D. A.; Dong, J.; Yang, J.; Song, X.; Nandakumar, S.; Kundra, R.; Lee, C.; Schultz, N.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save